ExploreWatchlistsPricing
  1. JP-listed companies
  2. KAKEN PHARMACEUTIAL CO., LTD.
  3. Financials
  4. Cash from operations

KAKEN PHARMACEUTIAL CO., LTD. (4521)

Market cap
¥191.8B
P/E ratio
68.7x
A Japanese pharmaceutical company that manufactures and sells medicines, medical devices, and agricultural chemicals while also operating real estate leasing.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash from operations (Million JPY)YoY (%)
Mar 31, 202529,780+1055.61%
Mar 31, 20242,577-72.15%
Mar 31, 20239,253-30.62%
Mar 31, 202213,336-7.26%
Mar 31, 202114,380-47.65%
Mar 31, 202027,468+30.00%
Mar 31, 201921,129-2.64%
Mar 31, 201821,703+41.60%
Mar 31, 201715,327-43.37%
Mar 31, 201627,067+83.67%
Mar 31, 201514,737

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat